Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 2, Pages 573
Publisher
MDPI AG
Online
2018-02-14
DOI
10.3390/ijms19020573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological effects and potential therapeutic targets of DT-13
- (2018) Ghulam Jilany Khan et al. BIOMEDICINE & PHARMACOTHERAPY
- Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma
- (2018) Xue Wang et al. CYTOKINE
- Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
- (2017) Rithwik Ramachandran et al. MOLECULAR PHARMACOLOGY
- New Concepts and Mechanisms of Platelet Activation Signaling
- (2017) Brian Estevez et al. PHYSIOLOGY
- Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand
- (2017) I. C. Moschonas et al. PLATELETS
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets
- (2017) Daniel Sánchez Centellas et al. THROMBOSIS RESEARCH
- Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease
- (2017) Rebecca J. Gryka et al. Drugs in research & development
- Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor TraffickingSingificance
- (2016) Jane E. Norman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protease-activated receptor 4: from structure to function and back again
- (2016) Shauna L French et al. BRITISH JOURNAL OF PHARMACOLOGY
- Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury
- (2016) Mikhail A. Kolpakov et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood
- (2016) S. L. French et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool
- (2016) Madhumita Chatterjee et al. PLATELETS
- Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent
- (2015) Shauna L. French et al. BLOOD REVIEWS
- Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)
- (2015) Michele M. Mumaw et al. THROMBOSIS RESEARCH
- Mechanism of Race-Dependent Platelet Activation Through the Protease-Activated Receptor-4 and Gq Signaling Axis
- (2014) Benjamin E. Tourdot et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Race Differences in Platelet Reactivity
- (2014) Michele M. Mumaw et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354
- (2014) Wandong Wen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
- (2014) L. C. Edelstein et al. BLOOD
- Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis
- (2014) M. M. Mumaw et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Biased Signaling of Protease-Activated Receptors
- (2014) Peishen Zhao et al. Frontiers in Endocrinology
- Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease
- (2013) M D Hollenberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c
- (2013) Leonard C Edelstein et al. NATURE MEDICINE
- Synthesis of Indole Derived Protease-Activated Receptor 4 Antagonists and Characterization in Human Platelets
- (2013) Summer E. Young et al. PLoS One
- Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions
- (2013) Kazuya Hosokawa et al. THROMBOSIS RESEARCH
- Platelet Biology and Receptor Pathways
- (2013) Giovanni Cimmino et al. Journal of Cardiovascular Translational Research
- The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
- (2012) Dominick J. Angiolillo DRUGS
- Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4
- (2012) María de la Fuente et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Role for Proteinase-activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR4)
- (2012) Margaret R. Cunningham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting proteinase-activated receptors: therapeutic potential and challenges
- (2012) Rithwik Ramachandran et al. NATURE REVIEWS DRUG DISCOVERY
- Structure, function and pathophysiology of protease activated receptors
- (2011) Mark N. Adams et al. PHARMACOLOGY & THERAPEUTICS
- Protease-Activated Receptor 4 Uses Anionic Residues To Interact with α-Thrombin in the Absence or Presence of Protease-Activated Receptor 1†
- (2008) Marvin T. Nieman BIOCHEMISTRY
- Protease-activated receptors as targets for antiplatelet therapy
- (2008) Justin R. Hamilton BLOOD REVIEWS
- Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives
- (2007) Hua-Sin Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started